New EPA rules force water providers to actually fix problems once detected
The Environmental Protection Agency (EPA) has announced it will revise the 1989 Total Coliform Rule, a national primary drinking water regulation, to achieve greater public health protection against microbial contamination in public water systems. While the original rule required utilities and munic...
This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!
The U.S. Department of State has announced that its Bureau of Cyberspace and Digital Policy (CDP) began operations in April 2022. The CDP comprises three policy groups: International Cybersecurity, International Information and Communications Policy, and Digital Freedom. The groups aim to address security and information freedom on the internet while looking to promote and protect U.S. interests. Companies doing business with the U.S. government or American companies may want to take note of and adopt any new cybersecurity recommendations that are announced by the CDP.
The European Commission released a "Restriction Roadmap," a political commitment to ban most toxic chemicals, as part of the zero-pollution goal in the EU Green Deal. Specifically, the ban aims to outlaw all flame retardants, bisphenols, per- and polyfluoroalkyl substances (PFAS), and all polyvinyl chloride chemicals. In the last few years, some EU countries have formally announced the intention to submit a restriction proposal for PFAS, and this blanket ban represents a rapid first step in the EU chemical strategy. Certain industries have already raised strong opposition and tried to water down early drafts of the plan, as the ban will affect over 12,000 chemicals present in 74% of consumer and professional products. If implemented, the ban will be the largest regulatory removal of authorized chemicals.
The U.S. FDA issued a denial in response to Bonumose's petition to exclude tagatose from "added sugars" on the U.S. Nutrition Facts panel. FDA issued an approval to exclude the rare sugar, allulose, in 2019. The agency's response letter indicated that the reason for denial was tagatose's higher caloric content compared with allulose. Bonumose issued a press release slamming the ruling as unfair and illogical as well as citing evidence of "FDA bias against health-focused innovation." This is certainly a blow to Bonumose and the likelihood that tagatose will become a widespread sugar reduction solution. It may boost demand for allulose and dash the hopes of producers of other sugar replacers, such as isomaltulose, which were hoping for exemptions.